Board of Directors

Mr. José María Fernández Sousa-Faro, Ph.D. Executive Chairman.

Mr. José María Fernández Sousa-Faro
Degree in Chemistry (1967) and a PhD in Biochemistry (1971) from Universidad Complutense, Madrid. Between 1971 and 1979, he was tenured professor and subsequently held the Chair of Biochemistry at the University of Santiago de Compostela.

MBA from IESE (Universidad de Navarra), Madrid.

He received an Honorary Doctorate from Universidad Antonio de Nebrija and was awarded Spain’s National Biotechnology Prize, both in 2009.

Professional career 
Between 1967 and 1979, he also worked at the following institutions: Institut für Physikalische Chemie at the University of Basel (Switzerland), Department of Molecular Biology at Washington University in Saint Louis, Missouri (USA), and L’Institut de Biologie Physico-Chimique at the Fondation Edmond de Rothschild in Paris, France, ICI Pharmaceuticals Division, Alderley Edge research labs and Shell (Sittingbourne research labs).

He has over 100 academic publications and patents in the fields of biochemistry, molecular biology, and anti-infective and anti-tumor drugs.

Between 1979 and 1985, Mr. Fernández Sousa-Faro was Research Director at Antibióticos S.A. He has been a member of the Board of the following companies: Antibióticos S.A., ICI-Farma S.A., Transportes Ferroviarios Especiales S.A. (Transfesa); Pescanova S.A.; Cooper Zeltia S.A.; Biolys S.A.; ICI-Zeltia S.A.; Penibérica S.A.; Banco Guipuzcoano S.A. and Zeltia S.A.

Current occupation 
Chairman of the Board of Directors of Pharma Mar S.A.

Chairman of the Board of Directors of Genomica S.A. and Sylentis, S.A.

Other positions 
Chairman of Fundación Bankinter para la Innovación.

Mr. Pedro Fernández Puentes. Executive Vice-Chairman.

Mr. Pedro Fernández Puentes
Degree in Chemistry from the University of Santiago de Compostela.

Professional career 
Between 1965 and 1971, he worked as Head of the new product development lab at Cooper Zeltia, S.A., and became Chairman of that company until it was demerged into Cooper Zeltia Veterinaria, S.A. and Consumo Zeltia S.A. (now, Zelnova Zeltia S.A.)

Chairman of Xylazel, S.A. from 1995 to 1997.

Member of the Board of Directors of ICI Farma S.A., ICI-Zeltia S.A., Corporación Noroeste S.A. and their main subsidiaries for approximately 20 years; Director of Zeltia S.A. from 1971 onwards.

Current occupation 
Chairman of Zelnova Zeltia S.A.
Director and Vice-Chairman of Pharma Mar S.A.

ROSP CORUNNA PARTICIPACIONES EMPRESARIALES, S.L. (represented by Mr. José Leyte Verdejo).

ROSP CORUNNA PARTICIPACIONES EMPRESARIALES, S.L. (represented by Mr. José Leyte Verdejo)
Degree in Law and Business from Comillas Pontifical University (ICADE).

Professional career 
After graduation, he worked for four years at Arthur Anderson Asesores Legales y Tributarios. He then joined Barclays Banks and was head of Deutsche Bank’s Private Banking department for Galicia and Asturias. Before taking his current position, he headed Caixa Galicia’s Private Banking division.

Current occupation 
Since 2000, he has been the chief executive of ROSP CORUNNA PARTICIPACIONES EMPRESARIALES, S.L., the family office of the late Rosalía Mera and now of her daughter, Sandra Ortega. Mr. Leyte Verdejo also teaches post-graduate courses at a number of academic institutions.

He was formerly a director of Zeltia S.A. and is currently a member of the Board of Directors of Pharma Mar on behalf of ROSP CORUNNA PARTICIPACIONES EMPRESARIALES, S.L.

Ms. Ana Palacio Vallelersundi

Mrs. Ana Palacio Vallelersundi
Degrees in Law, Sociology and Political Science (Special end of degree award). She is Honorary Doctorate from Georgetown University and in 2016 she has been awarded the O’Connor Justice Prize.

Professional career

She is an attorney specialized in international and European Union law, arbitration and mediation, and founder of the Palacio y Asociados Law firm.

Member of the European Parliament, where she chaired the Legal Affairs and Internal Market Committee, the Justice and Home Affairs Committee and the Conference of Committee Chairs (1994- 2002).

Spain’s Minister of Foreign Affairs from 2002 to 2004, Member of the Spanish Parliament in its VIII Legislature, timeframe in which she chaired the Joint Congress of Deputies and Senate Commission for the European Union (2004-2006).

Vice-President and General Counsel of the World Bank Group (2006-2008).

General Secretary of the International Centre for the Settlement of Investment Disputes (ICSID) (2006- 2008).

Executive Vice-President in charge of International Department of AREVA (2008-2009).

In March 2012, she was appointed an Elective Member of Spain’s Council of State, a position that she held until October 2018.

Other Board of Directors
Independent Coordinating Director of Enagas, S.A.

Director of AEE Power

Other positions

Advisory Boards of INVESTCORP and OCP

She sits on the Boards of a number of research centers and public institutions, including:

  • Energy Future initiative
  • MD Anderson Cancer Center
  • Atlantic Council (USA)
  • Conseil d'Orientation et de Réflexion de I'Assurance (CORA)
  • Advisory Board of Sandra Day O’Connor Justice Prize
  • Global Leadership Foundation
  • Institute for Human Sciences

In Spain, she is a member of the Scientific Board of Instituto Elcano and a trustee of Fundación para el Análisis y los Estudios Sociales (FAES), member of the Governing Council of Instituto de Empresa, European Council on Foreign Relations (ECFR) and Fundación Consejo España-EE.UU.

She has been visiting professor of the Edmund E. Walsh School of Foreign Service at Georgetown University since 2014.

Mr. José Félix Pérez-Orive Carceller. Vocal (other external)

Degree in Pharmacy from the University of Navarra and degree in Law; he obtained an MBA from IESE (Barcelona) in 1971.

Professional career 
He was manager of Antibióticos, S.A. in the USA from 1979 to 1984, and General Manager in Spain from 1984 to 1987.

He has been a director of over thirty companies and given over 100 lectures to major institutions.

He was a member of the Board of Directors of Zeltia S.A. from June 1990 onwards.

Current occupation 
Since 1987, he has been Chairman of Pérez Orive & Asociados, a company specialized in mergers and acquisitions.

Director of Pharma Mar, S.A.

Vice-Chairman of Xylazel, S.A., Director of Zelnova Zeltia S.A. and Genomica S.A., companies belong to Pharma Mar Group.

Ms. Montserrat Andrade Detrell.

Mrs. Montserrat Andrade Detrell
She holds a degree in Biology (1975) and a degree in Medicine (1983) and a diploma in Family and Community Medicine from Universidad Complutense, Madrid. She obtained a Master’s degree in Breast pathology from the University of Strasbourg, France (1991), a postgraduate diploma in Mammary Pathology from the University of Barcelona (1992), and a Master’s degree in that same field one year later; in 1996, she qualified as a specialist in Medicine of the Breast and Mammary Pathology from Universidad Complutense, Madrid.

Additionally, she is certified to supervise X-ray facilities for medical diagnostics by the Centro de Investigaciones Energéticas y Medioambientales y Tecnológicas attached to the Spanish Ministry of Industry and Energy (1991). She completed her internship at Hospital Universitario San Carlos in Madrid (1985–1988)

PhD from Universidad San Carlos (Madrid), and her degree dissertation at Universidad Complutense was granted honours.

She was Head of Institutional Relations at Zeltia S.A. from 2007 to 2012.

Current occupation 
She is currently member of the Board of Directors of Pharma Mar, S.A.

EDUARDO SERRA Y ASOCIADOS, S.L. (represented by Mr. Eduardo Serra Rexach). Vocal (other external)

EDUARDO SERRA Y ASOCIADOS, S.L. (represented by Mr. Eduardo Serra Rexach)
Degree in Law from Universidad Complutense (Madrid) and passed the exams to enter the Spanish civil service as a lawyer with the highest marks of that year.

Professional career 

He has held the following positions in the public sector: Chief of Staff to the Minister of Industry and Energy (1977-1979); General Secretary and Board Secretary of Spain’s National Industry Institute (INI) (1979-1982); Director of Banco del Crédito Industrial (1979-1982); Director of Butano (1979-1982); Vice-Chairman of Astilleros Españoles (1979-1982) and Chairman of Auxina (1979-1982); Under-Secretary of Defence (1982-1984); Secretary of State for Defence (1984-1987); Director of Instituto Nacional de Industria (1984-1987) and of Instituto Nacional de Hidrocarburos (INH) (1984-1987).

Spain’s Minister of Defence from 1996 to 2000.

In the private sector, from 1987 to 1996 he was Chairman of Telettra España, Vice-Chairman and subsequently Chairman of Cubiertas Mzov, Chairman of Peugeot-Talbot España, and Chairman of Airtel. From 2000 to 2006, he was Chairman of UBS España. He was Director of Zeltia, S.A.

He was also formerly Vice Chairman and Chairman of Instituto de Cuestiones Internacionales y Política Exterior (INCIPE) (1989-1996), Chairman of the Board of Trustees of Museo del Prado (2000-2004) and founding Chairman of Real Instituto Elcano (2001-2005) and Chairman of Fundación EVERIS (2005-2014).

Current occupation

Chairman of EVERIS.

Chairman of the consulting firm Eduardo Serra y Asociados, S.L.

Board member of Pharma Mar S.A.

Acts as director, advisor or trustee in numerous non-profit entities.

Mr. Carlos Solchaga Catalán.

Mr. Carlos Solchaga Catalán
Degree in Economics and Business from Universidad Complutense (Madrid), in 1966 and completed post-graduate studies at the Alfred P. Sloan School of Business at Massachusetts Institute of Technology (MIT) in 1971.

Professional career 
He began his career at the Bank of Spain, then transferred to the Instituto Nacional de Industria (INI) and subsequently to Banco de Vizcaya, where he was Director of Research and Advisor to the Chairman.

Spain’s Minister of Industry and Energy (1982-1985) and later Minister of Economy and Finance (1985-1993). Between 1991 and 1993, he was Chairman of the Internal Committee of the International Monetary Fund (IMF). He was a member of the Spanish parliament from 1980 to 1994, and headed the socialist parliamentary group between 1993 and 1994.

Current occupation  
Chairman of Solchaga Recio & Asociados.

Honorary President of Fundación Euroamérica.

Patron of Reina Sofía Museum Art Centre.

Chairman of Fundación Arquitectura y Sociedad

Chairman of the Advisory Board of Bufete Roca & Junyent.

Member of the Scientific Committee of Real Instituto Elcano.

Other Board of Directors

Director of Cie Automotive, S.A.

Mr. Valentín de Torres-Solanot del Pino.

Mr. Valentín de Torres-Solanot del Pino is a 57 year old Spanish businessman and entrepreneur, and holds a Degree in Public Works Engineering from Madrid Polytechnic University and a Degree in Civil Engineering from the UCAM (Catholic University of Murcia).

He has been a non-formal education lecturer at the EUITOP (Faculty of Civil Engineering) of the UPM and a formal education lecturer at the ETSECCP (Faculty of Civil Engineering) of the Polytechnic University of Catalonia (UPC).

Professional career

His professional career started more than 30 years ago in different entrepreneurial projects, most of which he spearheaded himself, in different sectors (education, auxiliary construction, engineering), and in all of them he has been committed to sharing and transferring know-how, always demonstrating his concern with the environment, equal opportunities and the removal of barriers of all types.

Current occupation

He is the owner and Managing Director of Copredije S.A., a company that provides Coordination Engineering services, celebrated its 20th anniversary on 13th March 2018 and was the first Spanish engineering company to subscribe to the 10 principles of the Global Compact. As the owner, Mr. Valentín de Torres-Solanot del Pino delegates day-to-day management duties to his team of collaborators.

He has basic knowledge of accounting and advanced knowledge of people, resources and business management.

As a long-term investor, he supports initiatives in various fields, which include his time at the Zeltia group company Noscira (formerly Neuroharma), where he was non-executive VicePresident and member of its Board of Directors.

He is acquainted with the world of biopharmaceutical —specifically, Oncology— research.

He has made multiple investments in Spanish startups and some from other countries, contributing his experience and eclectic character as an added value.

He is a founding member of E2IN2 S.A. and at present is coordinating Project CIVIE, which fully identifies with his concerns in different fields.

Mr. Carlos Pazos Campos, Independent.

Founding partner of King & Wood Mallesons in Spain. Lawyer with 30 years of experience,
specializes in national and international transactions. Throughout his professional career, he has
advised on all types of corporate operations such as acquisitions, transmissions, investments
and divestments of venture capital, transactions in secondary markets (OPAs and PVOs) and
corporate restructuring. He has participated as a legal advisor in several of the most important
M&A operations in the country, some of them with a high international component (United
States, France, United Kingdom, Portugal, Brazil, China, etc.).

He is currently one of the coordinators of advising foreign companies on their investments in
Spain and Latin America and advising Spanish companies on their business in the Asia-Pacific
region. He is currently responsible for the global strategy of King & Wood Mallesons for Latin
America.

In recent years, he has held positions on the boards of several companies, among the most
significant are:

  • Director of Hidroeléctrica del Cantábrico S.A. (2001 - 2002)
  • Advisor of the Board of Hidroeléctrica del Cantábrico S.A. (2002 - 2004)
  • Board member of EDP Energía Ibérica S.A. (2004 - 2005)
  • President and CEO of King & Wood Mallesons S.A.P. (1999 - present)
  • Non-Board Secretary and Legal Counsel of Vocento S.A. (2013 - currently)
    Training
  • Law degree from the Complutense University of Madrid (1987)
  • LLM in High European Studies by the College of Europe (Belgium) (1988)
  • LLM in International Business Law by the London School of Economics (United Kingdom)
    (honorable mention) (1989)

Awards and honours

  • PWC Award to the best paper in International Tax Law by London University (1989)

Publications

  • Current Legal Perspectives (Editorial Center of Studies Ramón Areces, 1995)
    Spanish Commercial Law (Telecommunications) (Butterworths, 1992)
  • The Legal System of the Private European Unit Account (Institute of Economic Studies,
    1990)
  • Founder and deputy editor of the magazine Derecho de los Negocios (Wolters Kluwer)

Languages

  • Galician (bilingual), English (bilingual), French (bilingual), Portuguese (bilingual), Italian (medium
    level)
Ms. Blanca Hernández Rodríguez.

Mrs Blanca Hernández Rodríguez has a degree in Economics and Business Administration
from the University of Seville. Degree in Humanities from the European University of Madrid
and Master's Degree in Finance from CUNEF.

Member of the Board of Directors of Ebro Foods, the Nomination & Remuneration
Committee and the Audit Committee. Since 2006, she serves as President of the Ebro Foods
Foundation, giving support to the company's CSR activities.

With a deep knowledge of investment and listed markets, she has more than 20 years’
experience in the financial sector. She began her professional career in the Arcalia group
and later assumed the start-up and management of a family office (Grupo Hisparroz).
She is currently the CEO of Grupo Tradifín, SL, a leading shareholder of Ebro Foods, and the
CEO and founder of Magallanes Value Investors, SGIIC, SA, asset manager under the
philosophy of investment value, in the long term and with, approximately, € 2,000m of
assets under management in several Collective Investment Institutions.

She serves on the IEAF board of directors.

She is member, among others, of the Capacis Foundation, Proyecto Hombre (Seville) and
Virgen de los Reyes Family Orientation Center (Seville). She serves on the Advisory Council
of Balia.

Corporate Bylaws

Shareholder Agreements

Board of Directors Regulation